P-254 FDG-PET response predicts overall and disease free survival after induction chemotherapy with docetaxel (D) plus carboplatin (C) and erythropoietin (EPO) in locally advanced (stage III) non-small cell lung cancer (NSCLC)

✍ Scribed by Griesinger, Frank; Glätzner, Tim; Schmidberger, Heinz; Andreas, Stefan; Schirren, Jörg; Dörge, Hilmar; Herse, Bernhard; Leupold, Holdger; Hemmerlein, Bernhard; Baum, Richard P.

• Book ID: 118571955
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 184 KB
• Volume: 41
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(03)92223-9